等待開盤 07-22 09:30:00 美东时间
+0.320
+0.78%
今日重点评级关注:Keybanc:维持迈威尔科技"超配"评级,目标价从385美元升至400美元;丰业银行:维持科尔黛伦矿业"跑赢大市"评级,目标价从27.5美元升至28.5美元
07-15 10:22
今日重点评级关注:HC Wainwright & Co.:维持艾吉纳斯"买入"评级,目标价从23美元升至30美元;富国银行:上调Q32 Bio评级至"超配",目标价66美元
07-14 11:36
Wells Fargo analyst Stephen Baxter maintains Pennant Gr (NASDAQ:PNTG) with a Overweight and raises the price target from $41 to $45.
07-13 22:02
U.S. RESEARCH ROUNDUP-BlackRock, Pennant Group, Weyerhaeuser Co July 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. listed companies, including BlackRock, Pennant Group and Weyerhaeuser Co on Friday. HIGHLIGHTS * BlackRock BLK.N : KBW raises ta
07-10 16:33
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Wells Fargo analyst Stephen Baxter maintains Pennant Gr (NASDAQ:PNTG) with a Overweight and raises the price target from $38 to $41.
05-08 21:13
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
今日重点评级关注:HC Wainwright & Co.:维持Solaris Resources"买入"评级,目标价从16美元升至18美元;Leerink Partners:维持Spyre Therapeutics"跑赢大市"评级,目标价从49美元升至106美元
04-14 10:44
Truist Securities analyst David Macdonald maintains Pennant Gr (NASDAQ:PNTG) with a Buy and raises the price target from $34 to $36.
04-14 01:02
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22